Clifford Bechtold
Compliance Officer en BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. .
Perfil
El Sr. Clifford Bechtold es director de operaciones de Biohaven Pharmaceutical Holding Co. Ltd. Anteriormente, el Sr. Bechtold trabajó como Vicepresidente de Operaciones Estratégicas en Adnexus y como Director de Personal en Bristol Myers Squibb Co. Se licenció en la Universidad Estatal de Dakota del Sur y se graduó en la Facultad de Medicina de la Universidad de Creighton.
Cargos activos de Clifford Bechtold
Empresas | Cargo | Inicio |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - |
BIOHAVEN LTD. | Compliance Officer | - |
Antiguos cargos conocidos de Clifford Bechtold.
Empresas | Cargo | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2013 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/10/2011 |
Formación de Clifford Bechtold.
South Dakota State University | Undergraduate Degree |
The Creighton University School of Medicine | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Clifford Bechtold